Positron emission tomography (PET): experience with a large-field-of-view three-dimensional PET scanner.
Positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose (FDG) is an accurate technique for staging and therapeutic monitoring in oncology. We evaluated our use of FDG PET in an oncology centre after our first 2500 studies, and summarise our experience of PET for the major referral indications. Optimised for clinical service, PET offers lower scanning costs and therefore improved cost-effectiveness.
Hicks
R J
RJ
Peter MacCallum Cancer Institute, Melbourne, VIC. rhicks@petermac.unimelb.edu.au
Binns
D S
DS
Fawcett
M E
ME
Ware
R E
RE
Kalff
V
V
McKenzie
A F
AF
Zalcberg
J P
JP
Peters
L J
LJ
D003362:Cost-Benefit Analysis; D004827:Epilepsy / Q000000981:diagnostic imaging; D005069:Evaluation Studies as Topic; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008485:Medical Audit; D008991:Monitoring, Physiologic / Q000379:methods; D009367:Neoplasm Staging / Q000379:methods; D009369:Neoplasms / Q000000981:diagnostic imaging*; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed / Q000191:economics; D014739:Victoria
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18